Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.

M Payen, Didier; Guilhot, Joelle; Launey, Yoann; Claire Lukaszewicz, Anne; Kaaki, Mahmoud; Veber, Benoit; Pottecher, Julien; Joannes-Boyau, Olivier; Martin-Lefevre, Laurent; Jabaudon, Matthieu; Mimoz, Olivier; Coudroy, Rémi; Ferrandière, Martine; Kipnis, Eric; Vela, Carlos; Chevallier, Stéphanie; Mallat, Jihad; Robert, René; Group, ABDOMIX

doi:10.1007/s00134-015-3751-z

Public

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.

Published in Intensive care medicine • Jun 1, 2015

NobleIDark:/48914/w1/20260526/61E653D6Record on NobleID

Authors:

Didier M Payen

,

Joelle Guilhot

,

Yoann Launey

Abstract

PURPOSE: To test whether the polymyxin B hemoperfusion (PMX HP) fiber column reduces mortality and organ failure in peritonitis-induced septic shock (SS) from abdominal infections. METHOD: Prospective, multicenter, randomized controlled trial in 18 French intensive care units from October 2010 to Ma...

Discussions